These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 36717819)

  • 21. Treatments, Outcomes, and Validity of Prognostic Scores in Patients With Sarcomatoid Renal Cell Carcinoma: A 20-Year Single-Institution Experience.
    Korenbaum C; Pierard L; Thiéry A; Story F; Lindner V; Lang H; Kurtz JE; Barthélémy P
    Clin Genitourin Cancer; 2018 Jun; 16(3):e577-e586. PubMed ID: 29395949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integrated genomic analysis identifies clinically relevant subtypes of renal clear cell carcinoma.
    Wu P; Liu JL; Pei SM; Wu CP; Yang K; Wang SP; Wu S
    BMC Cancer; 2018 Mar; 18(1):287. PubMed ID: 29534679
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evolution of Circulating Tumor DNA Profile from First-line to Subsequent Therapy in Metastatic Renal Cell Carcinoma.
    Pal SK; Sonpavde G; Agarwal N; Vogelzang NJ; Srinivas S; Haas NB; Signoretti S; McGregor BA; Jones J; Lanman RB; Banks KC; Choueiri TK
    Eur Urol; 2017 Oct; 72(4):557-564. PubMed ID: 28413127
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metastatic Chromophobe Renal Cell Carcinoma: Presence or Absence of Sarcomatoid Differentiation Determines Clinical Course and Treatment Outcomes.
    Ged Y; Chen YB; Knezevic A; Casuscelli J; Redzematovic A; DiNatale RG; Carlo MI; Lee CH; Feldman DR; Patil S; Hakimi AA; Russo P; Motzer RJ; Voss MH
    Clin Genitourin Cancer; 2019 Jun; 17(3):e678-e688. PubMed ID: 31036466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mutations in renal cell carcinoma.
    D'Avella C; Abbosh P; Pal SK; Geynisman DM
    Urol Oncol; 2020 Oct; 38(10):763-773. PubMed ID: 30478013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of laterality in renal cell carcinoma: A population-based study from the surveillance, epidemiology, and end results (SEER) database.
    Guo S; Yao K; He X; Wu S; Ye Y; Chen J; Wu CL
    Cancer Med; 2019 Sep; 8(12):5629-5637. PubMed ID: 31407495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Langerhans Cell Histiocytosis Associated With Renal Cell Carcinoma Is a Neoplastic Process: Clinicopathologic and Molecular Study of 7 Cases.
    Agaimy A; Bonert M; Naqvi A; Wang C; Trpkov K; Dettmar P; Wintzer HO; Stoehr R; Hes O; Williamson SR; Gibson IW; Hartmann A
    Am J Surg Pathol; 2020 Dec; 44(12):1658-1665. PubMed ID: 32910018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mucinous Tubular and Spindle-Cell Carcinoma of the Kidney: Clinical Features, Genomic Profiles, and Treatment Outcomes.
    Ged Y; Chen YB; Knezevic A; Donoghue MTA; Carlo MI; Lee CH; Feldman DR; Patil S; Hakimi AA; Russo P; Voss MH; Motzer RJ
    Clin Genitourin Cancer; 2019 Aug; 17(4):268-274.e1. PubMed ID: 31151928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comprehensive texture feature analysis framework of renal cell carcinoma: pathological, prognostic, and genomic evaluation based on CT images.
    Wu K; Wu P; Yang K; Li Z; Kong S; Yu L; Zhang E; Liu H; Guo Q; Wu S
    Eur Radiol; 2022 Apr; 32(4):2255-2265. PubMed ID: 34800150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinicopathological features and prognosis of fumarate hydratase deficient renal cell carcinoma].
    Yu YF; He SM; Wu YC; Xiong SW; Shen Q; Li YY; Yang F; He Q; Li XS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Aug; 53(4):640-646. PubMed ID: 34393221
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lactate dehydrogenase A is a potential prognostic marker in clear cell renal cell carcinoma.
    Girgis H; Masui O; White NM; Scorilas A; Rotondo F; Seivwright A; Gabril M; Filter ER; Girgis AH; Bjarnason GA; Jewett MA; Evans A; Al-Haddad S; Siu KM; Yousef GM
    Mol Cancer; 2014 May; 13():101. PubMed ID: 24885701
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genomics of Clear-cell Renal Cell Carcinoma: A Systematic Review and Meta-analysis.
    Bui TO; Dao VT; Nguyen VT; Feugeas JP; Pamoukdjian F; Bousquet G
    Eur Urol; 2022 Apr; 81(4):349-361. PubMed ID: 34991918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploration of immune-related genes in high and low tumor mutation burden groups of chromophobe renal cell carcinoma.
    Li L; Chen X; Hao L; Chen Q; Liu H; Zhou Q
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32662515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metastatic renal cell carcinoma to the pancreas: Clinical features and treatment outcome.
    Shin TJ; Song C; Jeong CW; Kwak C; Seo S; Kang M; Chung J; Hong SH; Hwang EC; Park JY; Lee H
    J Surg Oncol; 2021 Jan; 123(1):204-213. PubMed ID: 33047324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Are primary renal cell carcinoma and metastases of renal cell carcinoma the same cancer?
    Semeniuk-Wojtaś A; Stec R; Szczylik C
    Urol Oncol; 2016 May; 34(5):215-20. PubMed ID: 26850779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of PD-1 and PD-L1 expression in patients with metastatic clear cell renal cell carcinoma.
    Ueda K; Suekane S; Kurose H; Chikui K; Nakiri M; Nishihara K; Matsuo M; Kawahara A; Yano H; Igawa T
    Urol Oncol; 2018 Nov; 36(11):499.e9-499.e16. PubMed ID: 30131293
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Broad spectrum mutational analysis of chromophobe renal cell carcinoma using next-generation sequencing.
    Mollica V; Franceschini T; Gruppioni E; Rizzo A; Ricci C; Schiavina R; Brunocilla E; Ardizzoni A; Fiorentino M; Giunchi F; Massari F
    Pathol Res Pract; 2021 Mar; 219():153350. PubMed ID: 33556910
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
    Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
    [No Abstract]   [Full Text] [Related]  

  • 39. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients.
    Lagerwaard FJ; Levendag PC; Nowak PJ; Eijkenboom WM; Hanssens PE; Schmitz PI
    Int J Radiat Oncol Biol Phys; 1999 Mar; 43(4):795-803. PubMed ID: 10098435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognosis of renal cell carcinoma with bone metastases: Experience from a large cancer centre.
    Ruatta F; Derosa L; Escudier B; Colomba E; Guida A; Baciarello G; Loriot Y; Fizazi K; Albiges L
    Eur J Cancer; 2019 Jan; 107():79-85. PubMed ID: 30551078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.